Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

Condition:   Hematological Malignancy Intervention:   Genetic: Genetically engineered NK cells Sponsor:   Fate Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials